ImPasstion130 Trial in TNBC

Debra Patt, MD, Executive Vice President, Strategic Initiatives, Academic Programs, Texas Oncology shares the results of the ImPassion130, a phase III study that adds atezolizumab to 1st line chemothe... Author: obr Added: 07/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts